Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Carisma Therapeutics ( (CARM) ) just unveiled an announcement.
On January 6, 2025, Carisma Therapeutics was notified by Nasdaq that it failed to meet the minimum bid price requirement for continued listing on the Nasdaq Global Market. Despite being given a grace period until July 7, 2025, the company did not regain compliance, leading to a potential delisting threat. Following a hearing, Nasdaq allowed Carisma to transfer its listing to the Nasdaq Capital Market effective June 12, 2025, with a deadline to meet all listing criteria by October 7, 2025. To address this, Carisma scheduled a special stockholders’ meeting for August 5, 2025, to approve a reverse stock split aimed at increasing its share price and maintaining its listing status.
The most recent analyst rating on (CARM) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Carisma Therapeutics stock, see the CARM Stock Forecast page.
Spark’s Take on CARM Stock
According to Spark, TipRanks’ AI Analyst, CARM is a Neutral.
Carisma Therapeutics’ overall stock score reflects significant financial challenges and valuation concerns. The weak financial performance, characterized by persistent losses and liquidity issues, is the primary factor holding back the score. Although technical analysis shows some short-term bullish signals, the negative P/E ratio and absence of dividends highlight valuation risks. Addressing operational inefficiencies and improving financial health are crucial for enhancing the company’s stock attractiveness.
To see Spark’s full report on CARM stock, click here.
More about Carisma Therapeutics
Carisma Therapeutics Inc. operates in the biotechnology industry, focusing on the development of innovative therapies. The company is primarily engaged in creating targeted treatments for various diseases, with a market focus on maintaining its listing on major stock exchanges.
Average Trading Volume: 14,782,746
Technical Sentiment Signal: Sell
Current Market Cap: $16.72M
See more data about CARM stock on TipRanks’ Stock Analysis page.